Skip to main content
. 2022 Apr 18;6(24):6274–6281. doi: 10.1182/bloodadvances.2021006283

Table 2.

Cumulative incidence of VTE in patients with blood type O (n = 653) and non-O (n = 1055) divided in intermediate/low-risk and high-risk tumor types at 3-, 6-, 12-, and 24-month follow-up

Cumulative VTE-incidence (%) [95% confidence interval]
3 mo 6 mo 12 mo 24 mo
Overall
 Blood type O 3.8 [2.5-5.5] 5.7 [4.1-7.7] 7.0 [5.1-9.1] 7.6 [5.7-9.9]
 Blood type non-O 3.4 [2.4-4.7] 6.5 [5.1-8.1] 8.4 [6.8-10.2] 10.2 [8.4-12-2]
Intermediate/ low-risk cancer types
 Blood type O 2.4 [1.3-4.0] 3.4 [2.0-5.2] 4.6 [3.0-6.7] 5.0 [3.3-7.1]
 Blood type non-O 3.0 [2.0-4.3] 5.4 [4.0-7.1] 6.8 [5.2-8.6] 8.6 [6.8-10.6]
High-risk cancer types
 Blood type O 9.2 [5.0-14.9] 14.7 [9.2-21.3] 16.2 [10.5-23.1] 17.9 [11.8-24.9]
 Blood type non-O 5.2 [2.7-9.0] 11.1 [7.1-16.0] 15.5 [10.7-21.1] 17.3 [12.3-23.1]